Chemoinformaics analysis of CEDR-8-EN-15-OL
Molecular Weight | 220.356 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
Exact Molecular Weight | 220.183 | nRing | 3 |
Solubility: LogS | -4.08 | nHRing | 0 |
Solubility: LogP | 3.79 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 1 | BPOL | 24.077 |
QED | 0.672 |
Synth | 5.69 |
Natural Product Likeliness | 3.471 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.406 |
MDCK | 0.0000211 |
BBB | 0.957 |
PPB | 0.85382 |
VDSS | 1.112 |
FU | 0.153505 |
CYP1A2-inh | 0.117 |
CYP1A2-sub | 0.241 |
CYP2c19-inh | 0.066 |
CYP2c19-sub | 0.821 |
CYP2c9-inh | 0.16 |
CYP2c9-sub | 0.381 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.496 |
CYP3a4-inh | 0.164 |
CYP3a4-sub | 0.211 |
CL | 10.204 |
T12 | 0.124 |
hERG | 0.004 |
Ames | 0.007 |
ROA | 0.105 |
SkinSen | 0.086 |
Carcinogencity | 0.111 |
EI | 0.952 |
Respiratory | 0.963 |
NR-Aromatase | 0.021 |
Antiviral | Yes |
Prediction | 0.920979 |